
Opinions
Paul Harris, CFA
Teva PharmaceuticalTEVABUYNov 29, 2016
$37.86
Stock price when the opinion was issued
$31.48
As of Jun 18, 2026. Market Open.
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Most of their business is in generics. Recently made a big acquisition which they are working through, which is one of the reasons it has come off. At these levels, this is a great time to buy.